US Stock MarketDetailed Quotes
CMND Clearmind Medicine
- 1.1900
- +0.0199+1.70%
Close May 3 16:00 ET
- 1.1400
- -0.0500-4.20%
Post 18:59 ET
3.88MMarket Cap-63P/E (TTM)
1.2300High1.1500Low72.64KVolume1.1900Open1.1701Pre Close85.39KTurnover2.26%Turnover RatioLossP/E (Static)3.26MShares23.700052wk High0.77P/B3.82MFloat Cap0.920552wk Low--Dividend TTM3.21MShs Float183.0000Historical High--Div YieldTTM6.84%Amplitude0.9205Historical Low1.1750Avg Price1Lot Size
Clearmind Medicine Key Stats
Quarterly+Annual
YOY
| (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | (Q3)Jul 31, 2022 | (Q2)Apr 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 52.89%-1.46M | -66.50%-4.56M | -1,563.39%-370.91K | -469.96%-1.13M | 104.32%48.26K | -121.63%-3.1M | -63.29%-2.74M | 97.27%-22.3K | 39.94%-198.35K | -144.18%-1.12M |
| Net income from continuing operations | 27.99%-1.37M | -23.04%-6.23M | -193.29%-2.8M | 53.80%-522.29K | 24.65%-1.01M | -15.93%-1.9M | -130.38%-5.07M | 13.28%-954.8K | -30.86%-1.13M | -755.21%-1.34M |
| Operating gains losses | -843.92%-41.67K | 826.80%1.98M | --2.06M | ---343.78K | --258.33K | --5.6K | --213.51K | ---- | ---- | ---- |
| Depreciation and amortization | -60.76%8.63K | -31.87%41.59K | -92.86%1.23K | -57.91%14.31K | 1,196.39%4.05K | 131.15%21.99K | 3,914.99%61.04K | 1,032.78%17.22K | --33.99K | --312.7498 |
| Deferred tax | 5,856.25%201.5K | -42.75%12.56K | -63.44%8.02K | ---4.72K | --5.88K | --3.38K | --21.94K | --21.94K | --0 | --0 |
| Other non cash items | -99.96%1 | -80.18%2.1K | -104.53%-91.0071 | --229.3511 | ---428.3157 | --2.39K | --10.61K | --2.01K | ---- | ---- |
| Change In working capital | 80.43%-296.11K | -177.11%-700.7K | -42.02%320.64K | -181.11%-352.59K | 3,099.41%844.23K | -2,875.35%-1.51M | 5,814.15%908.72K | 348.12%553.04K | -18.55%434.69K | 90.62%-28.15K |
| -Change in receivables | 147.98%93.57K | -863.16%-111.81K | 108.19%4.03K | -137.78%-42.48K | 255.64%121.66K | -758.03%-195.03K | 115.71%14.65K | -23.58%-49.26K | -55.78%112.44K | 74.40%-78.17K |
| -Change in prepaid assets | 59.65%-276.5K | -124.96%-18.9K | 3,108.64%84.15K | 621.80%79.28K | 2,628.27%502.93K | -1,496.15%-685.26K | 180.00%75.7K | 97.04%-2.8K | --10.98K | --18.43K |
| -Change in payables and accrued expense | 58.35%-222.36K | -169.65%-570K | -61.58%232.46K | -225.10%-389.39K | 282.29%120.76K | -311.99%-533.82K | 302.65%818.37K | 784.53%605.09K | 11.39%311.26K | 493.93%31.59K |
| -Change in other working capital | 210.42%109.18K | ---- | ---- | ---- | ---- | ---98.88K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 52.89%-1.46M | -66.50%-4.56M | -1,563.39%-370.91K | -469.96%-1.13M | 104.32%48.26K | -121.63%-3.1M | -63.29%-2.74M | 97.27%-22.3K | 39.94%-198.35K | -144.18%-1.12M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -363.97%-18.97K | -505.81%-24.76K | 97.25%-4.09K | 97.09%-4.09K | ||||||
| Net PPE purchase and sale | ---- | --0 | ---- | ---- | ---- | ---- | 79.14%-4.09K | ---- | ---- | ---- |
| Net intangibles purchase and sale | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net other investing changes | ---- | ---18.97K | ---24.76K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | -363.97%-18.97K | -505.81%-24.76K | ---- | ---- | ---- | 97.25%-4.09K | 97.09%-4.09K | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -16.25%5.32M | 2,143.29%8.43M | 4,106.05%1.45M | 347.12%182.6K | -6.52%454.34K | 6.35M | -91.35%375.98K | 97.66%-36.18K | -101.65%-73.89K | 486.05K |
| Net issuance payments of debt | 60.09%-6.3K | 43.18%-29.59K | 108.64%1.28K | 78.02%-8.19K | ---6.91K | ---15.78K | ---52.07K | ---14.82K | ---37.25K | --0 |
| Net common stock issuance | -71.33%1.82M | 1,777.63%8.04M | 4,882.98%1.02M | 620.70%190.78K | -5.10%461.25K | --6.36M | -90.16%428.06K | 98.62%-21.35K | -100.82%-36.64K | --486.05K |
| Proceeds from stock option exercised by employees | --3.5M | --426.68K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -16.25%5.32M | 2,143.29%8.43M | 2,112.63%1.45M | 579.81%182.6K | -6.52%454.34K | --6.35M | -91.35%375.98K | 95.34%-72.01K | -100.85%-38.06K | --486.05K |
| Net cash flow | ||||||||||
| Beginning cash position | 4,114.84%5.43M | -96.24%93.12K | 875.13%2.9M | 569.01%3.84M | 52.89%3.37M | -96.43%128.78K | 1,169.81%2.48M | -94.38%297.64K | -49.46%574.09K | 1,088.27%2.2M |
| Current changes in cash | 18.79%3.85M | 263.18%3.86M | 1,784.13%1.05M | -246.06%-942.14K | 179.81%502.6K | 331.73%3.24M | -193.69%-2.36M | 97.50%-62.57K | -106.54%-272.24K | -167.02%-629.78K |
| Effect of exchange rate changes | 188.14%3.72K | -63.93%-27.29K | -61.16%-27.27K | 708.21%883.1533 | 590.23%3.32K | -1,234.23%-4.22K | ---16.64K | ---16.92K | --109.2729 | --481.179 |
| End cash Position | 175.60%9.29M | 4,047.73%3.92M | 4,047.73%3.92M | 875.13%2.9M | 569.01%3.84M | 52.89%3.37M | -96.52%94.62K | -96.52%94.62K | -94.38%297.64K | -49.46%574.09K |
| Free cash flow | 52.89%-1.46M | -66.25%-4.56M | -1,305.70%-370.91K | -469.96%-1.13M | 104.32%48.26K | -121.63%-3.1M | -51.20%-2.74M | 97.21%-26.39K | 39.92%-198.35K | -139.90%-1.12M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg